Font Size: A A A

Pennington Cancer Institute Cancer Conference

Cancer screening, early detection, and treatment are rapidly changing, with new technologies and therapies being introduced. This year almost 2 million Americans will be diagnosed with cancer. Therefore, it is critical for primary care providers to remain current with guidelines. Understanding the initial cancer therapy is also essential for optimal patient care, as patients often seek information from multiple sources, including their primary providers. This conference will address numerous topics related to common forms of cancer commonly seen and often diagnosed by PCPs.

15th Annual VA2K Walk & Roll

The free event is open to employees, Veterans, their families, and members of the community. The VA2K Walk & Roll is meant to promote physical activity within the workday, benefit the homeless Veteran program through in-kind donations, and incorporate a health fair along the 2K route to introduce participants to internal and community resources for both Veteran and Employee-facing programs/partners.

More than 800 people participated in the 2024 event!

NCC will be on hand with Colleen, the Inflatable Colon. 

Colorectal Cancer Mortality Disparities Learning Community for Coalitions

The CRC Mortality Disparities Learning Community is ideal for coalitions prioritizing CRC initiatives. The five learning community sessions will include panel discussions, brief presentations, small group breakouts and Q&A time with subject matter experts and peers and will help increase your capacity to integrate interventions mitigating colorectal cancer mortality disparities into the cancer planning process.  

Webinar: What You Need to Know About Prostate Cancer Screening

American Cancer Society presents this webinar for Cancer Coalitions.

This webinar will discuss the history & biology of PSA testing and its clinical use; as well as explore the process of shared decision making, how it can best be implemented by doctors, and what patients need to consider in order to make an informed decision about being screened for prostate cancer.

Prevent Cancer Dialogue: Minimal Residual Disease (MRD): Exploring the impact on cancer early detection and personalized care

In this session, speakers will delve into the cutting-edge science of Minimal Residual Disease (MRD) testing, a revolutionary approach to cancer detection. We’ll explore how these tests can help determine prognosis/relapse risk, find early recurrence and individualize treatment to improve patient outcomes. 

Register here.

Prevent Cancer Dialogue: Diversifying Clinical Trial Participation

In this session, speakers will share best practices and key barriers in connecting patients to clinical trials following a cancer diagnosis. We will explore novel approaches to improve patient recruitment, retention and equitable access to clinical trials.  More details to come! 

Register here.

Prevent Cancer Dialogue: Updates on Young-Onset Cancers

Cases of young-onset cancer – cancer diagnosed in individuals ages 18-49 – have been rising at alarming rates. What do we really know about this trend? What do providers need to understand so that symptoms aren’t missed in their younger patients? In this session, speakers will provide an update on the latest information related to young-onset breast and colorectal cancers, as well as current research and known risk factors. We will also explore potential strategies to address this concerning trend. Moderated discussion and Q&A will immediately follow speaker presentations. 

Rural HPV Vaccination Learning Community

The American Cancer Society (ACS) and the ACS National HPV Vaccination Roundtable (HPVRT) are inviting rural healthcare partners to join a collaborative learning community aimed at connecting partners and improving on-time HPV vaccination rates among adolescents aged 9–13.

The Learning Community offers an opportunity to collaborate, share insights, and gain valuable knowledge to help combat HPV-related cancers in rural populations. By participating, you will have access to:

CELL Series: Expanding Access to Cervical Cancer Screening: The Role of Self-Collection

Join us for a discussion on the emerging role of self-collection for cervical cancer screening and its potential to improve access, especially in rural and trauma-informed care settings. Learn about the SHIP Trial, how self-collection compares to traditional screening methods, and when we might expect to see broader implementation.

Featuring:

Deanna Kepka, PhD, MPH
College of Nursing & Huntsman Cancer Institute
University of Utah

Register here.